Medicare AdvantageFebruary 28, 2021
Access to more claim denial information is now self-service
Effective for dates of service on and after April 1, 2021, the following specialty pharmacy drugs and corresponding codes from current Clinical Criteria noted below will be included in our medical step therapy precertification review process. Step therapy review applies upon precertification initiation or renewal in addition to the current medical necessity review.
Clinical Criteria |
Status |
Drug(s) |
HCPCS codes |
ING-CC-0011 |
Nonpreferred |
Ocrevus®, injection, 1 mg |
J2350 |
ING-CC-0160 |
Nonpreferred |
Eptinezumab, injection 1 mg |
J3032 |
The Clinical Criteria is publicly available on our provider website. Visit the Clinical Criteria website to search for specific Clinical Criteria.
What if I need assistance?
If you have questions about this communication or need assistance with any other item, contact your local Provider Relations representative.
To view this article online:
Or scan this QR code with your phone